PPI Use Doesn't Up Recurrence of Bacterial Peritonitis

Share this content:
PPI Use Doesn't Up Recurrence of Bacterial Peritonitis
PPI Use Doesn't Up Recurrence of Bacterial Peritonitis

THURSDAY, Nov. 10, 2016 (HealthDay News) -- For patients with cirrhosis with previous spontaneous bacterial peritonitis (SBP), proton pump inhibitor (PPI) use is not associated with SBP recurrence, according to a study published online Nov. 7 in the Journal of Gastroenterology and Hepatology.

Jung Hee Kim, from the Sungkyunkwan University School of Medicine in Seoul, South Korea, and colleagues conducted a retrospective study to examine the impact of PPI use on incidence of recurrent SBP in a population of patients with cirrhosis with a previous SBP. The risk of second SBP was compared for the PPI and non-PPI groups before and after propensity score matching.

The researchers found that a second SBP occurred in 29.3 percent of PPI users during a mean of 52.1 ± 5.2 months and in 24.1 percent of nonusers during a mean of 61.9 ± 4.8 months (P = 0.185). Second SBP similarly occurred in both groups in the matched cohort (29.3 versus 26.8 percent; P = 0.271). The only significant risk factor for second SBP was Child-Pugh score in multivariate analysis (hazard ratio, 1.68). In the matched cohort, isolated bacteria and clinical outcomes such as mortality, presence of sepsis, and hospital stay did not differ between the groups.

"PPI use is not a risk factor for recurrent SBP in cirrhotic patients," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Factors ID'd to Predict Fatty Liver in Obese Teens

Factors ID'd to Predict Fatty Liver in Obese ...

African-American obese teens more susceptible to fatty liver effects on glucose metabolism

Patients Prefer Doctors Who Engage in Face-to-Face Visits

Patients Prefer Doctors Who Engage in Face-to-Face Visits

Patients perceive F2F physicians as more compassionate and better communicators

Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

Absolute risks for colorectal cancer, CRC death not reduced for screening group vs. controls in women

is free, fast, and customized just for you!

Already a member?

Sign In Now »